Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged &#8805;60 Years.

Eliakim-Raz, Noa; Leibovici-Weisman, Yaara; Stemmer, Amos; Ness, Asaf; Awwad, Muhammad; Ghantous, Nassem; Stemmer, Salomon M

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.

Eliakim-Raz, Noa; Leibovici-Weisman, Yaara; Stemmer, Amos; Ness, Asaf; Awwad, Muhammad; Ghantous, Nassem; Stemmer, Salomon M.

Eliakim-Raz N; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.
Leibovici-Weisman Y; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.
Stemmer A; Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel.
Ness A; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.
Awwad M; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.
Ghantous N; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.
Stemmer SM; Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel.

JAMA ; 326(21): 2203-2204, 2021 12 07.

Article in English | MEDLINE | ID: covidwho-1593083

Subject(s)

Antibodies, Viral/blood; COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Immunoglobulin G/blood; RNA, Messenger/immunology; RNA, Viral/immunology; SARS-CoV-2/immunology; Aged; Aged, 80 and over; Antibodies, Viral/immunology; BNT162 Vaccine; COVID-19/immunology; COVID-19 Vaccines/genetics; COVID-19 Vaccines/immunology; Female; Humans; Immunoglobulin G/immunology; Male; Middle Aged; RNA, Messenger/administration & dosage; RNA, Messenger/blood; RNA, Viral/administration & dosage; RNA, Viral/genetics; SARS-CoV-2/genetics; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / RNA, Messenger / RNA, Viral / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.19885

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google